Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

Pre-revenue biotechs need cash to be sustainable, now that's a novel concept. All the FUDs here won't stop IPIX from getting a deal. 20 CDAs and counting...

"Successfully securing partnerships would afford the Company access to immediate and potentially recurring sources of non-dilutive capital, including upfront fees, milestone-based payments and tiered royalties;"

http://www.ipharminc.com/press-release/2018/1/29/innovation-pharmaceuticals-brilacidin-franchise-anchored-in-three-clinical-indications-oral-mucositis-inflammatory-bowel-disease-and-serious-skin-infections-expands-into-dermatologic-diseases

The balance sheet is not sustainable. They need cash soon